Here are some top stories on Healio.com/OSN from the past week:
Iluvien approved for new indication in UK
The United Kingdom has added a new indication for Iluvien, approving it for the prevention of relapse in recurrent noninfectious uveitis affecting the posterior segment of the eye. Read more.
Novartis completes Alcon spin-off
Shares of Alcon, the world’s largest eye care device company, began trading Tuesday on the SIX Swiss Exchange and the New York Stock Exchange under the symbol ALC. Read more.
TearSolutions completes $6.4 million financing
TearSolutions has completed $6.4 million in financing to complete a pivotal FDA phase 2 clinical trial of its lead product candidate Lacripep. Read more.
Full-thickness corneal transplants with cataract surgery still have a role
The corneal triple procedure, either combined or staged, has undergone significant evolution in the past several decades. Read more.
Surgeon offers pearls on using toric lenses in keratoconus cases
Toric IOLs can be a viable option in patients with astigmatism and keratoconus. Read more.